Opinion|Videos|March 17, 2025
Episode 3 Video: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
Author(s)Wayne Kuang, MD, Matt T. Rosenberg, MD
Wayne Kuang, MD; and Matt T. Rosenberg, MD, discuss how overactive bladder presents with distinct pathophysiological mechanisms between genders, requires different diagnostic approaches when distinguishing from benign prostatic hyperplasia in men, impacts quality of life in older adults, benefits from early primary care intervention, and necessitates improved patient advocacy and educational initiatives for optimal management outcomes.
Advertisement
Episodes in this series
Notes:
0:00-9:35 Dual Diagnosis: OAB and BPH
9:36-13:10 Understanding Symptoms of OAB
13:11-17:25 Managing OAB
17:26-28:44 Treatment Options for OAB
28:45-35:08 Role of Primary Care Providers
35:09-41:37 Educational Outreach in OAB
Advertisement
Related to this article
Delayed diagnosis and skipped nodal staging worsen penile cancer outcomes, according to Luis G. Medina, MD.
Butterfly Medical has also submitted a premarket approval application to the FDA.
Moderators and participants reviewed ARANOTE, ARACOG, and ARASEC data and how they inform individualized treatment for mCSPC.
Timothy N. Clinton, MD, recaps bladder cancer data from the 2026 AUA Northeastern Section meeting, including BOND-003 cretostimogene results and safety data on mitomycin intravesical solution.
Juan J. Andino, MD, MBA, discusses surgical decision-making in prolonged ischemic priapism and how ischemia duration affects erectile dysfunction risk and treatment timing.
Jack R. Andrews, MD, discusses BED-PSMA-411 findings comparing PSMA-PET detection rates and urinary excretion in prostate cancer biochemical recurrence.
Sandip Prasad, MD, MPhil, discusses ENVISION trial findings on mitomycin for intravesical solution and patient selection in clinical practice.
OpenFlo incorporates a design that modifies key mechanical features of conventional Foley catheters.
Advertisement
Advertisement
Trending on Urology Times
1
Study compares PSMA-PET radiopharmaceuticals in prostate cancer recurrence
2
Butterfly Prostatic Retraction Device granted EU MDR certification for BPH
3
Matching mCSPC treatment to the patient, not just the trial data
4
Timothy Clinton, MD, reviews bladder cancer data from 2026 AUA Northeastern Section Meeting
5